These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 32360595)
1. Vitamin D regulation of HAS2, hyaluronan synthesis and metabolism in triple negative breast cancer cells. Narvaez CJ; Grebenc D; Balinth S; Welsh JE J Steroid Biochem Mol Biol; 2020 Jul; 201():105688. PubMed ID: 32360595 [TBL] [Abstract][Full Text] [Related]
2. The natural antisense transcript HAS2-AS1 regulates breast cancer cells aggressiveness independently from hyaluronan metabolism. Parnigoni A; Caon I; Teo WX; Hua SH; Moretto P; Bartolini B; Viola M; Karousou E; Yip GW; Götte M; Heldin P; Passi A; Vigetti D Matrix Biol; 2022 May; 109():140-161. PubMed ID: 35395387 [TBL] [Abstract][Full Text] [Related]
3. IL-6 Impairs the Activity of Vitamin D3 in the Regulation of Epithelial-Mesenchymal Transition in Triple Negative Breast Cancer. Abdel-Mohsen MA; Abo Deif SM; Abou-Shamaa LA Asian Pac J Cancer Prev; 2019 Aug; 20(8):2267-2273. PubMed ID: 31450894 [TBL] [Abstract][Full Text] [Related]
4. Syndecan-1 Depletion Has a Differential Impact on Hyaluronic Acid Metabolism and Tumor Cell Behavior in Luminal and Triple-Negative Breast Cancer Cells. Valla S; Hassan N; Vitale DL; Madanes D; Spinelli FM; Teixeira FCOB; Greve B; Espinoza-Sánchez NA; Cristina C; Alaniz L; Götte M Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070901 [TBL] [Abstract][Full Text] [Related]
7. Sirtuin 1 reduces hyaluronan synthase 2 expression by inhibiting nuclear translocation of NF-κB and expression of the long-noncoding RNA HAS2-AS1. Caon I; Bartolini B; Moretto P; Parnigoni A; Caravà E; Vitale DL; Alaniz L; Viola M; Karousou E; De Luca G; Hascall VC; Passi A; Vigetti D J Biol Chem; 2020 Mar; 295(11):3485-3496. PubMed ID: 31932306 [TBL] [Abstract][Full Text] [Related]
8. VDR in salivary gland homeostasis and cancer. DeSantis KA; Robilotto SL; Matson M; Kotb NM; Lapierre CM; Minhas Z; Leder AA; Abdul K; Facteau EM; Welsh J J Steroid Biochem Mol Biol; 2020 May; 199():105600. PubMed ID: 31958633 [TBL] [Abstract][Full Text] [Related]
9. Hyaluronan synthase 2 (HAS2) overexpression diminishes the procatabolic activity of chondrocytes by a mechanism independent of extracellular hyaluronan. Ishizuka S; Tsuchiya S; Ohashi Y; Terabe K; Askew EB; Ishizuka N; Knudson CB; Knudson W J Biol Chem; 2019 Sep; 294(37):13562-13579. PubMed ID: 31270213 [TBL] [Abstract][Full Text] [Related]
10. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer. Thakkar A; Wang B; Picon-Ruiz M; Buchwald P; Ince TA Breast Cancer Res Treat; 2016 May; 157(1):77-90. PubMed ID: 27120467 [TBL] [Abstract][Full Text] [Related]
11. Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice. Zinser GM; McEleney K; Welsh J Mol Cell Endocrinol; 2003 Feb; 200(1-2):67-80. PubMed ID: 12644300 [TBL] [Abstract][Full Text] [Related]
12. Cell Energy Metabolism and Hyaluronan Synthesis. Caon I; Parnigoni A; Viola M; Karousou E; Passi A; Vigetti D J Histochem Cytochem; 2021 Jan; 69(1):35-47. PubMed ID: 32623953 [TBL] [Abstract][Full Text] [Related]
13. HYBID (alias KIAA1199/CEMIP) and hyaluronan synthase coordinately regulate hyaluronan metabolism in histamine-stimulated skin fibroblasts. Yoshida H; Aoki M; Komiya A; Endo Y; Kawabata K; Nakamura T; Sakai S; Sayo T; Okada Y; Takahashi Y J Biol Chem; 2020 Feb; 295(8):2483-2494. PubMed ID: 31949043 [TBL] [Abstract][Full Text] [Related]
14. Comparative regulation of gene expression by 1,25-dihydroxyvitamin D3 in cells derived from normal mammary tissue and breast cancer. Beaudin SG; Robilotto S; Welsh J J Steroid Biochem Mol Biol; 2015 Apr; 148():96-102. PubMed ID: 25239595 [TBL] [Abstract][Full Text] [Related]
15. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors. Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760 [TBL] [Abstract][Full Text] [Related]
16. Enhanced hexosamine metabolism drives metabolic and signaling networks involving hyaluronan production and O-GlcNAcylation to exacerbate breast cancer. Chokchaitaweesuk C; Kobayashi T; Izumikawa T; Itano N Cell Death Dis; 2019 Oct; 10(11):803. PubMed ID: 31645543 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of HAS2 and hyaluronic acid production by 1,25-Dihydroxyvitamin D Narvaez CJ; LaPorta E; Robilotto S; Liang J; Welsh J Oncotarget; 2020 Jul; 11(30):2889-2905. PubMed ID: 32774770 [TBL] [Abstract][Full Text] [Related]
18. Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells. Li Y; Li L; Brown TJ; Heldin P Int J Cancer; 2007 Jun; 120(12):2557-67. PubMed ID: 17315194 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of hybrid vitamin D receptor agonist/histone deacetylase inhibitors in vitamin D-resistant triple-negative 4T1 breast cancer. Bijian K; Kaldre D; Wang TT; Su J; Bouttier M; Boucher A; Alaoui-Jamali M; White JH; Gleason JL J Steroid Biochem Mol Biol; 2018 Mar; 177():135-139. PubMed ID: 28847749 [TBL] [Abstract][Full Text] [Related]
20. Has2 natural antisense RNA and Hmga2 promote Has2 expression during TGFβ-induced EMT in breast cancer. Kolliopoulos C; Lin CY; Heldin CH; Moustakas A; Heldin P Matrix Biol; 2019 Jul; 80():29-45. PubMed ID: 30194979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]